Yuanbao Inc. Fiscal Year 2025 Financial Review

Yuanbao Inc. Fiscal Year 2025 Financial Review

Yuanbao posts 14th straight profitable quarter with $168.1M revenue as AI model network expands to 4,900 models supporting insurance operations.

FedEx Q3 Earnings Preview: Analysts Expect 8.6% EPS Decline to $4.12 Despite Revenue Growth

FedEx reports Q3 fiscal 2026 results March 19 with consensus at $4.12 EPS, down 8.6% year-over-year despite revenue growth—margin trajectory…

General Mills, Inc. (GIS) Misses Q3 EPS Estimates by 12.1%

General Mills, Inc. (GIS) delivered Q3 2026 GAAP earnings of $0.64 per share, below analysts' $0.73 forecast (miss by 12.1%).

Red Cat (RCAT) Q4 Revenue Surges 315.8% to $26.2M, Tops Estimates Despite $0.17 Loss

Red Cat's Q4 loss of $0.17/share missed estimates as revenue surged 316% year-over-year to $26.2M, topping consensus by 10%.

Envela (ELA) Q4 EPS of $0.23 Crushes Estimate by 156%, Revenue Surges 66.6% YoY to $80.5M

Envela's Q4 EPS of $0.23 crushed the $0.09 estimate by $0.14 per share, while revenue of $80.5M topped consensus by…

Heartflow (HTFL) Stock Surges 13% as Q4 Revenue of $49.1M Beats Estimates Despite $0.12 Loss

Heartflow posts wider-than-expected Q4 loss of $0.29/share but revenue tops estimates by 5.6%, driving 13% stock surge on growth optimism.

DLocal’s Strong 2025 Finish

DLocal's Q4 EPS of $0.36 crushed the $0.18 estimate by 96%, while revenue of $337.9M beat consensus and surged 65%…

Micron Technology’s Fiscal Q2 2026 Financial Review

Micron crushes Q2 estimates with $12.20 EPS vs $8.73 consensus, revenue up 196% YoY to $23.86B as AI memory demand…

Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates

Dogwood Therapeutics posts Q4 loss of $0.26/share, 69.8% narrower than the $0.86 consensus, as clinical-stage biotech reduces burn rate.

General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B

General Mills Q3 EPS of $0.64 missed estimates by 12.1% as strategic pricing investments weighed on results; management reaffirms guidance,…